| |
| |
|
| Insider
Information: |
Lurker Nancy |
| Relationship: |
|
| City: |
Saddle River |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,392,856 |
|
|
Indirect Shares
|
232,889 |
|
|
| Direct
Value |
$1,804,781 |
|
|
|
Indirect Value
|
$200,308 |
|
|
| Total
Shares |
1,625,745 |
|
|
| Total
Value |
$2,005,089 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
1.0
|
| Percentage
Gain/Loss : |
 -48.1%
|
 6.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Interpace Biosciences Inc |
IDXG |
CEO, Director |
2015-03-05 |
1,298,998 |
2015-03-05 |
106,000 |
Premium* |
|
|
Mallinckrodt plc |
MNK |
Director |
2016-03-16 |
10,507 |
2013-07-18 |
0 |
Premium* |
|
|
EyePoint Pharmaceuticals Inc |
EYPT |
|
2024-02-13 |
83,351 |
2024-02-13 |
126,889 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2024-02-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
74,681 |
126,889 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2024-02-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
74,681 |
83,351 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2024-02-09 |
4 |
D |
$28.80 |
$430,358 |
D/D |
(14,943) |
158,032 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,534 |
172,975 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2024-01-24 |
4 |
S |
$24.98 |
$748,250 |
D/D |
(29,956) |
135,441 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2024-01-23 |
4 |
S |
$24.97 |
$125,950 |
D/D |
(5,044) |
165,397 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2024-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
75,133 |
193,484 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2024-01-06 |
4 |
D |
$20.40 |
$470,077 |
D/D |
(23,043) |
170,441 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2023-12-28 |
4/A |
GA |
$0.00 |
$0 |
I/I |
52,208 |
52,208 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2023-12-28 |
4/A |
GD |
$0.00 |
$0 |
D/D |
52,208 |
118,351 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2023-12-04 |
4 |
S |
$20.76 |
$415,200 |
D/D |
(20,000) |
170,559 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
CEO |
• • – |
2023-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,533 |
190,559 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,466 |
150,281 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,717 |
137,815 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2022-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,533 |
124,098 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2021-11-15 |
4 |
AS |
$20.15 |
$201,480 |
D/D |
(10,000) |
103,546 |
0 |
% |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2021-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,500 |
113,546 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,467 |
109,046 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,717 |
96,579 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2020-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
124,667 |
784,467 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2020-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,000 |
659,800 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2020-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,000 |
619,800 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2020-03-10 |
4 |
B |
$1.06 |
$104,027 |
D/D |
98,000 |
574,800 |
0.01 |
% |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2020-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
137,174 |
476,800 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2019-10-12 |
4 |
D |
$2.11 |
$22,618 |
D/D |
(10,745) |
314,455 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
